(Q38170681)

30 August 2017

title

Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa (English)

1 reference

30 August 2017

0 references

1 reference

cervix uterine cancer

1 reference

based on heuristic

inferred from title

author name string

Rengaswamy Sankaranarayanan

1

1 reference

30 August 2017

Rose Anorlu

2

1 reference

30 August 2017

Ghislain Sangwa-Lugoma

3

1 reference

30 August 2017

Lynette A Denny

4

1 reference

30 August 2017

language of work or name

English

0 references

publication date

1 December 2013

1 reference

30 August 2017

1 reference

30 August 2017

volume

31 Suppl 5

1 reference

30 August 2017

page(s)

F47-52

1 reference

Clinical trials of cancer screening in the developing world and their impact on cancer healthcare

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Changing cancer incidence in Kampala, Uganda, 1991-2006.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Human papillomavirus, cancer and vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

A review of clinical trials of human papillomavirus prophylactic vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Financing HPV vaccination in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Achieving high coverage in Rwanda's national human papillomavirus vaccination programme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Implementation of human papillomavirus immunization in the developing world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

The promise of global cervical-cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

A critical assessment of screening methods for cervical neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Accuracy of visual inspection with acetic acid for cervical cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Analysis of the effectiveness of visual inspection with acetic acid/Lugol's iodine in one-time and annual follow-up screening in rural China.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Visual screening for early detection of cervical neoplasia in Angola

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Cervical cancer screening with naked-eye visual inspection in Colombia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Evaluation of cervical visual inspection screening in Dar es Salaam, Tanzania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Effect of cough technique and cryogen gas on temperatures achieved during simulated cryotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Effect of the "cough technique" on cryotherapy freezing temperature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Performance of cryotherapy devices using nitrous oxide and carbon dioxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Training for cervical cancer prevention programs in low-resource settings: focus on visual inspection with acetic acid and cryotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

A 5-day educational program for teaching cervical cancer screening using visual inspection with acetic acid in low-resource settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Human papillomavirus testing in the prevention of cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Nucleic acid tests for the detection of alpha human papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Self-sampling of the vaginal fluid at home combined with high-risk HPV testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Cost-effectiveness analysis of cervical cancer prevention based on a rapid human papillomavirus screening test in a high-risk region of China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.066

10.1016/J.VACCINE.2012.06.066

7 January 2021

Identifiers

DOI

1 reference

30 August 2017

1 reference